Study Title,Study Short Name,Study Description,Accession,Study Type,Link to Study Landing Page,Link to Organizational Network,Responsible Party,Other Information
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID),ORCHID,"ORCHID is a multicenter, blinded, placebo-controlled, randomized clinical trial evaluating hydroxychloroquine for the treatment of adults hospitalized with COVID-19. Patients, treating clinicians, and study personnel will all be blinded to study group assignment.",phs002299.v1.p1,Interventional (Clinical Trial),https://clinicaltrials.gov/ct2/show/NCT04332991,PETAL Network,"Boyd Taylor Thompson, Massachusetts General Hospital","Access to ORCHID data requires data access approvals from the NLM Database of Genotypes and Phenotypes (dbGaP) system. ORCHID data is also available to those with appropriate access permission on BioLINCC (https://biolincc.nhlbi.nih.gov/studies/petal_orchid/), where they may download the data. Researchers using ORCHID data may find helpful the reproducible code originally used by the ORCHID research team to arrive at their results. It is available in BioData Catalyst Powered by PIC-SURE, for which there is more information in a Jupyter notebook (https://bit.ly/2PWVS7U)."
RED CORAL: PETAL Repository of Electronic Data COVID-19 Observational Study,RED CORAL,We will identify acute and critically ill patients with COVID-19 and collect detailed data from their hospital stay. We will contribute data to the WHO/ ISARIC COVID registry and to the scientific community in order to advance United States participation in studies of global epidemiology. We will use the data to increase understanding of the clinical course of COVID-19.,phs002363.v1.p1,Observational,https://petalnet.org/studies/public/redcoral,PETAL Network,,
